These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Maini RN; Breedveld FC; Kalden JR; Smolen JS; Furst D; Weisman MH; St Clair EW; Keenan GF; van der Heijde D; Marsters PA; Lipsky PE; Arthritis Rheum; 2004 Apr; 50(4):1051-65. PubMed ID: 15077287 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis]. Wiland P; Głowska A; Chlebicki A; Szechiński J Pol Arch Med Wewn; 2002 Nov; 108(5):1055-63. PubMed ID: 12685246 [TBL] [Abstract][Full Text] [Related]
4. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. Kavanaugh A; St Clair EW; McCune WJ; Braakman T; Lipsky P J Rheumatol; 2000 Apr; 27(4):841-50. PubMed ID: 10782805 [TBL] [Abstract][Full Text] [Related]
5. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784 [TBL] [Abstract][Full Text] [Related]
7. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis. Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF; J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005 [TBL] [Abstract][Full Text] [Related]
8. Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial. Ferraccioli GF; Assaloni R; Di Poi E; Gremese E; De Marchi G; Fabris M Rheumatology (Oxford); 2002 Oct; 41(10):1109-12. PubMed ID: 12364628 [TBL] [Abstract][Full Text] [Related]
9. [Infliximab in the treatment of rheumatoid arthritis]. Akahoshi T; Watabe H Nihon Rinsho; 2002 Dec; 60(12):2378-83. PubMed ID: 12510365 [TBL] [Abstract][Full Text] [Related]
10. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab]. D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis. Marchesoni A; Sarzi Puttini P; Gorla R; Caporali R; Arnoldi C; Atzeni F; Vianelli M; Pallavicini FB Clin Exp Rheumatol; 2005; 23(6):916-7. PubMed ID: 16396721 [No Abstract] [Full Text] [Related]
12. Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in an open-label clinical trial. Kalden JR; Nüsslein HG; Wollenhaupt J; Burmester GR; Krüger K; Antoni C Clin Exp Rheumatol; 2008; 26(5):834-40. PubMed ID: 19032816 [TBL] [Abstract][Full Text] [Related]
13. Rituximab for rheumatoid arthritis. Practical guidance for optimizing treatment. Furfaro N Adv Nurse Pract; 2008 Jan; 16(1):61-4. PubMed ID: 20014746 [No Abstract] [Full Text] [Related]
14. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN; N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166 [TBL] [Abstract][Full Text] [Related]
15. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis. Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791 [TBL] [Abstract][Full Text] [Related]
16. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study. Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Breedveld FC; Dijkmans BA; Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767 [TBL] [Abstract][Full Text] [Related]
17. Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab. Allanore Y; Sellam J; Batteux F; Job Deslandre C; Weill B; Kahan A Clin Exp Rheumatol; 2004; 22(6):756-8. PubMed ID: 15638051 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of reducing duration of infliximab infusion. Fukuyo S; Saito K; Yamaoka K; Sawamukai N; Hirata S; Nawata M; Iwata S; Tanaka Y Mod Rheumatol; 2014 Mar; 24(2):275-80. PubMed ID: 24251990 [TBL] [Abstract][Full Text] [Related]
19. Anti-tumor necrosis factor therapies. Taylor PC Curr Opin Rheumatol; 2001 May; 13(3):164-9. PubMed ID: 11333343 [TBL] [Abstract][Full Text] [Related]
20. [Infliximab combined with methotrexate in the treatment of rheumatoid arthritis]. Sfriso P; Botsios C; Ostuni P; Todesco S Recenti Prog Med; 2002; 93(7-8):416-20. PubMed ID: 12138686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]